Commodore Capital LP Vera Therapeutics, Inc. Transaction History
Commodore Capital LP
- $1.16 Billion
- Q1 2024
A detailed history of Commodore Capital LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 3,165,000 shares of VERA stock, worth $120 Million. This represents 11.79% of its overall portfolio holdings.
Number of Shares
3,165,000
Previous 5,450,000
41.93%
Holding current value
$120 Million
Previous $83.8 Million
62.82%
% of portfolio
11.79%
Previous 8.75%
Shares
3 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$200 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$126 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$112 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$106 Million7.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.39MShares$90.9 Million0.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.03B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...